PACS Group's 46% Stock Rally Amid Audit Probe and SEC Filing Delays

Introduction

PACS Group, Inc. (NYSE: PACS) is a holding company founded in 2013 that invests in post-acute care facilities, senior living communities, and related ancillary services. Through its 316 independent operating subsidiaries across 17 states, PACS serves more than 30,000 patients daily. On November 17, 2025, PACS shares closed at $15.52, reflecting a 46.69 percent increase, on a trading volume of 4,823,497 shares.

Corporate Structure and Personnel

PACS employs between 201 and 500 corporate staff who provide accounting, human resources, legal support, and risk management to its licensed healthcare subsidiaries. Co-founders Jason Murray and Mark Hancock each bring over 20 years of executive experience in acute and post-acute care settings. The board includes professionals like Jacque Millard and Taylor Leavitt, highlighting a management team with industry knowledge and financial expertise.

Post-acute care by Martha Dominguez de Gouveia

Recent Developments and News

In June 2025, PACS entered into forbearance agreements with Omega Healthcare Investors and certain lenders, allowing temporary reprieve on lease and debt payments while maintaining a minimum liquidity of $100 million. The same month, President P.J. Sanford resigned and engaged in a consultation arrangement.
On September 11, 2025, PACS disclosed via Form 8-K the resignation of CFO Derick Apt, the appointment of an interim CFO, and the addition of an interim compliance chief.
On November 6, 2025, a subsequent Form 8-K confirmed that PACS is conducting an independent Audit Committee investigation into its financial statements from early and mid-2024 while projecting record revenue and adjusted EBITDA for the first half of 2025. As of June 30, 2025, the company reported an occupancy rate of 88.9 percent, above the industry average of 78 percent, and cash reserves of $294.2 million. The New York Stock Exchange extended PACS’s deadline to complete financial restatements to November 19, 2025.
On November 17, 2025, PACS filed Form NT 10-Q, notifying of its inability to timely file the quarterly report for the period ending September 30, 2025.
In November 2024, Hindenburg Research published allegations suggesting that PACS engaged in improper Medicare billing during the COVID-19 emergency. Federal agencies are reportedly investigating those claims, and several class-action lawsuits remain active.

Financial and Strategic Analysis

According to Yahoo Finance, for the twelve months ended September 2025, PACS reported:

• Revenue: $3.56 billion
• Net income: $92.29 million
• EPS (TTM): $0.61
• Profit margin: 2.59 percent
• Total cash (most recent quarter): $73.37 million
• Total debt/equity (most recent quarter): 469.36 percent

Valuation multiples include a trailing P/E of 17.47, forward P/E of 4.72, PEG ratio of 0.31, price/sales of 0.45, and price/book of 2.87. The enterprise value stands at $4.24 billion, representing 1.19 times revenue and 19.62 times EBITDA. Since Q2 2024, PACS added 96 facilities, reflecting its strategy of both organic growth and acquisitions within post-acute care.

Market Position and Industry Context

PACS is among the largest post-acute care platforms in the United States and is the second-largest nursing home chain by facility count. Its portfolio includes 32,000 skilled nursing beds and 2,400 assisted living beds, with a majority of facilities holding four- or five-star CMS ratings. The company’s occupancy rate of 88.9 percent is above the industry average, though third-party analyses have identified staffing and inspection ratings below national standards in certain areas. PACS’s diversified model—encompassing skilled nursing, senior living, and ancillary services—aligns with demographic trends associated with an aging population and a growing demand for post-acute care.

tl;dr

PACS Group shares increased by 46.69 percent to $15.52 on November 17, 2025. The company is facing delayed SEC filings, with an extended deadline from the NYSE to complete financial restatements by November 19, 2025, and is currently under an ongoing Audit Committee investigation related to its financial statements from early to mid-2024. Management anticipates record first-half 2025 revenue and adjusted EBITDA, supported by an occupancy rate of 88.9 percent and cash reserves of $294.2 million as of June 30, 2025. Federal investigations regarding allegations from November 2024 and multiple class actions are also ongoing.